To compare the effects of different progestins in combined oral contraceptives (COC) on sexual functions and well- being of women. In this prospective and observational study, 52 participants used drosperinone, 48 participants used gestodene, 55 participants used levonorgestrele and 60 participants used non- hormonal contraception. All participants completed the Female Sexual Function Index (FSFI) and Beck Depression Inventory (BDI) at baseline and after six cycles of treatment.
In the hormonal contraception group, there was a statistically significant improvement between FSFI scores at baseline and after six cycles of treatment. In each hormonal contraception subgroup, there was no significant difference between FSFI scores.
In the hormonal contraception group, there was a statistically significant increase between BDI scores at baseline and after six cycles of treatment. In each hormonal contraception subgroup, there was no significant difference between BDI scores. These data show that COC pills make positive effects on female sexuality. Androgenic or antiandrogenic progestins have similar improvements on female sexual function. In addition, COC pills have negative impacts on depression.
Birincil Dil | İngilizce |
---|---|
Bölüm | Articles |
Yazarlar | |
Yayımlanma Tarihi | 2 Haziran 2015 |
Yayımlandığı Sayı | Yıl 2015 Cilt: 20 Sayı: 1 |